Literature DB >> 26026820

The role of CCN family genes in haematological malignancies.

J E Wells1, M Howlett1, L C Cheung1, Ursula R Kees2.   

Abstract

Haematological malignancies, although a broad range of specific disease types, continue to show considerable overlap in classification, and patients are treated using similar chemotherapy regimes. In this review we look at the role of the CCN family of matricellular proteins and indicate their role in nine haematological malignancies including both myeloid and lymphoid neoplasms. The potential for further haematological neoplasms with CCN family associations is argued by summarising the demonstrated role of CCN family genes in the differentiation of haematopoietic stem cells (HSC) and mesenchymal stem cells. The expanding field of knowledge encompassing CCN family genes and cancers of the HSC-lineage highlights the importance of extracellular matrix-interactions in both normal physiology and tumorigenesis of the blood, bone marrow and lymph nodes.

Entities:  

Keywords:  CCN; Cancer; Haematopoietic stem cell (HSC); Mesenchymal stem cell (MSC)

Year:  2015        PMID: 26026820      PMCID: PMC4580684          DOI: 10.1007/s12079-015-0296-4

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  98 in total

1.  Nov/CCN3 regulates long-term repopulating activity of murine hematopoietic stem cells via integrin αvβ3.

Authors:  Jun Ishihara; Terumasa Umemoto; Masayuki Yamato; Yoshiko Shiratsuchi; Satoshi Takaki; Brian G Petrich; Hiromitsu Nakauchi; Koji Eto; Toshio Kitamura; Teruo Okano
Journal:  Int J Hematol       Date:  2014-02-22       Impact factor: 2.490

2.  Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.

Authors:  Huining Kang; I-Ming Chen; Carla S Wilson; Edward J Bedrick; Richard C Harvey; Susan R Atlas; Meenakshi Devidas; Charles G Mullighan; Xuefei Wang; Maurice Murphy; Kerem Ar; Walker Wharton; Michael J Borowitz; W Paul Bowman; Deepa Bhojwani; William L Carroll; Bruce M Camitta; Gregory H Reaman; Malcolm A Smith; James R Downing; Stephen P Hunger; Cheryl L Willman
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

3.  Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment.

Authors:  V Lokesh Battula; Ye Chen; Maria da Graca Cabreira; Vivian Ruvolo; Zhiqiang Wang; Wencai Ma; Sergej Konoplev; Elizabeth Shpall; Karen Lyons; Dirk Strunk; Carlos Bueso-Ramos; Richard Eric Davis; Marina Konopleva; Michael Andreeff
Journal:  Blood       Date:  2013-06-05       Impact factor: 22.113

4.  Expression and physiological role of CCN4/Wnt-induced secreted protein 1 mRNA splicing variants in chondrocytes.

Authors:  Takeshi Yanagita; Satoshi Kubota; Harumi Kawaki; Kazumi Kawata; Seiji Kondo; Teruko Takano-Yamamoto; Shinji Tanaka; Masaharu Takigawa
Journal:  FEBS J       Date:  2007-04       Impact factor: 5.542

5.  Connective Tissue Growth Factor reporter mice label a subpopulation of mesenchymal progenitor cells that reside in the trabecular bone region.

Authors:  Wen Wang; Sara Strecker; Yaling Liu; Liping Wang; Fayekah Assanah; Spenser Smith; Peter Maye
Journal:  Bone       Date:  2014-10-22       Impact factor: 4.398

6.  CCN3 suppresses mitogenic signalling and reinstates growth control mechanisms in Chronic Myeloid Leukaemia.

Authors:  Lynn McCallum; Wanhua Lu; Susan Price; Noureddine Lazar; Bernard Perbal; Alexandra E Irvine
Journal:  J Cell Commun Signal       Date:  2011-07-20       Impact factor: 5.782

7.  Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.

Authors:  Milena Sant; Claudia Allemani; Carmen Tereanu; Roberta De Angelis; Riccardo Capocaccia; Otto Visser; Rafael Marcos-Gragera; Marc Maynadié; Arianna Simonetti; Jean-Michel Lutz; Franco Berrino
Journal:  Blood       Date:  2010-07-27       Impact factor: 22.113

Review 8.  Functions and mechanisms of action of CCN matricellular proteins.

Authors:  Chih-Chiun Chen; Lester F Lau
Journal:  Int J Biochem Cell Biol       Date:  2008-08-15       Impact factor: 5.085

Review 9.  Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer.

Authors:  Julia E Wells; Meegan Howlett; Catherine H Cole; Ursula R Kees
Journal:  Int J Cancer       Date:  2014-05-30       Impact factor: 7.396

10.  NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells.

Authors:  Rajeev Gupta; Dengli Hong; Francisco Iborra; Samantha Sarno; Tariq Enver
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

View more
  6 in total

1.  Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma.

Authors:  Afak Rasheed Salman Zaidi; Sadie Dresman; Charlotte Burt; Simon Rule; Lynn McCallum
Journal:  J Cell Commun Signal       Date:  2018-11-21       Impact factor: 5.782

Review 2.  Cell surface receptors for CCN proteins.

Authors:  Lester F Lau
Journal:  J Cell Commun Signal       Date:  2016-04-20       Impact factor: 5.782

3.  Differential Expression of Ccn4 and Other Genes Between Metastatic and Non-metastatic EL4 Mouse Lymphoma Cells.

Authors:  Manpreet S Chahal; H Teresa Ku; Zhihong Zhang; Christian M Legaspi; Angela Luo; Mandi M Hopkins; Kathryn E Meier
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

4.  CCN family of proteins: critical modulators of the tumor cell microenvironment.

Authors:  Herman Yeger; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2016-08-12       Impact factor: 5.782

5.  Reduced NOV expression correlates with disease progression in colorectal cancer and is associated with survival, invasion and chemoresistance of cancer cells.

Authors:  Jun Li; Lin Ye; Ping-Hui Sun; Fei Zheng; Fiona Ruge; Lucy K Satherley; Yi Feng; Huishan Zhao; Guifang Du; Tingting Wang; Yao Yang; Xuemei Ma; Shan Cheng; Xiaomei Yang; Hefen Yu; Xu Teng; Yang Si; Zhongtao Zhang; Wen G Jiang
Journal:  Oncotarget       Date:  2017-04-18

6.  Polymorphisms of the CYR61 gene in patients with acute myeloid leukemia in a Han Chinese population.

Authors:  Chang-Chun Niu; Ya-Fang Wan; Cheng Yang; Tian Li; Pu Liao
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.